Duke Clinical Research Institute

• 

  People

  • Administrative Positions

    • Curtis, Lesley H., Interim Executive Director, Duke Clinical Research Institute
    • Hernandez, Adrian Felipe, Vice Dean and Executive Director of Duke Clinical Research
    • Naggie, Susanna, Vice Dean for Clinical Research
    • Wang, Tracy Yu-Ping, Director of Health Services & Outcomes Research

  • Memberships

    • Al-Khalidi, Hussein Rashid, Membership in the Duke Clinical Research Institute
    • Al-Khatib, Sana Mustapha, Member in the Duke Clinical Research Institute
    • Alexander, John Hunter Peel, Member in the Duke Clinical Research Institute
    • Alexander, Karen Patton, Member in the Duke Clinical Research Institute
    • Allen LaPointe, Nancy Marie, Member in the Duke Clinical Research Institute
    • Allen, Andrew Scott, Member in the Duke Clinical Research Institute
    • Anderson, Monique, Membership in the Duke Clinical Research Institute
    • Anstrom, Kevin J., Member in the Duke Clinical Research Institute
    • Armstrong, Sarah Commisso, Member of the Duke Clinical Research Institute
    • Balevic, Stephen Joseph, Member of the Duke Clinical Research Institute
    • Barnhart, Huiman Xie, Member in the Duke Clinical Research Institute
    • Becker, Mara, Member in the Duke Clinical Research Institute
    • Becker, Richard Clinton, Member in the Duke Clinical Research Institute
    • Benjamin Jr., Daniel Kelly, Member in the Duke Clinical Research Institute
    • Bettger, Janet Prvu, Member in the Duke Clinical Research Institute
    • Bhosai, Satasuk Joy, Member in the Duke Clinical Research Institute
    • Bloomfield, Gerald, Member in the Duke Clinical Research Institute
    • Brennan, J. Matthew, Member in the Duke Clinical Research Institute
    • Burnett, Bruce Kendall, Member of the Duke Clinical Research Institute
    • Califf, Robert M., Member of the Duke Clinical Research Institute
    • Carin, Lawrence, Member of the Duke Clinical Research Institute
    • Carlson, David, Member of the Duke Clinical Research Institute
    • Chatterjee, Ranee, Member in the Duke Clinical Research Institute
    • Chow, Shein-Chung, Member in the Duke Clinical Research Institute
    • Chu, Vivian Hou, Member in the Duke Clinical Research Institute
    • Clough, Jeffrey David, Member in the Duke Clinical Research Institute
    • Cohen-Wolkowiez, Michael, Member in the Duke Clinical Research Institute
    • Cook, Chad E., Member in the Duke Clinical Research Institute
    • Corey, Gordon Ralph, Member in the Duke Clinical Research Institute
    • Corneli, Amy Lynn, member of the Duke Clinical Research Institute
    • Cowper, Patricia Agnes, Member in the Duke Clinical Research Institute
    • Crowley, Matthew Janik, Member in the Duke Clinical Research Institute
    • Curtis, Lesley H., Member in the Duke Clinical Research Institute
    • Daubert, James Patrick, Member in the Duke Clinical Research Institute
    • Daubert, Melissa Anne, Member in the Duke Clinical Research Institute
    • DeLong, Elizabeth Ray, Member in the Duke Clinical Research Institute
    • DeVore, Adam David, Member in the Duke Clinical Research Institute
    • Dinan, Michaela Ann, Membership in the Duke Clinical Research Institute
    • Dolor, Rowena Joy, Member in the Duke Clinical Research Institute
    • Douglas, Pamela Susan, Member in the Duke Clinical Research Institute
    • Dunn, Jessilyn, Member in the Duke Clinical Research Institute
    • Dupre, Matthew E., Membership in the Duke Clinical Research Institute
    • Durheim, Michael Thomas, Membership in the Duke Clinical Research Institute
    • Eapen, Zubin John, Member in the Duke Clinical Research Institute
    • Edmonston, Daniel Len, Member in the Duke Clinical Research Institute
    • Eisenstein, Eric Leo, Member in the Duke Clinical Research Institute
    • Felker, Gary Michael, Member in the Duke Clinical Research Institute
    • Fisher, Deborah Anne, Member in the Duke Clinical Research Institute
    • Fowler Jr., Vance Garrison, Member in the Duke Clinical Research Institute
    • Fudim, Marat, Member in the Duke Clinical Research Institute
    • Gellad, Ziad F., Member in the Duke Clinical Research Institute
    • George, Steven Zachary, Member in the Duke Clinical Research Institute
    • Gierisch, Jennifer M., Member in the Duke Clinical Research Institute
    • Goertz, Christine, Member in the Duke Clinical Research Institute
    • Goldstein, Benjamin Alan, Member of the Duke Clinical Research Institute
    • Gonzalez, Juan Marcos, Member of the Duke Clinical Research Institute
    • Goode, Adam Payne, Member in the Duke Clinical Research Institute
    • Granger, Christopher Bull, Member in the Duke Clinical Research Institute
    • Green, Cynthia Lea, Member in the Duke Clinical Research Institute
    • Green, Jennifer Brigitte, Member in the Duke Clinical Research Institute
    • Greenberg, Rachel Gottron, Member in the Duke Clinical Research Institute
    • Greene, Stephen, Member in the Duke Clinical Research Institute
    • Guptill, Jeffrey, Member in the Duke Clinical Research Institute
    • Hammill, Bradley Gordon, Member in the Duke Clinical Research Institute
    • Harrison, Robert William, Membership in the Duke Clinical Research Institute
    • Hasselblad, Victor, Member in the Duke Clinical Research Institute
    • Henao, Ricardo, Member of the Duke Clinical Research Institute
    • Hernandez, Adrian Felipe, Member in the Duke Clinical Research Institute
    • Hill, Kevin Dennis, Member in the Duke Clinical Research Institute
    • Holland, Thomas Lawrence, Membership in the Duke Clinical Research Institute
    • Hong, Hwanhee, Member in the Duke Clinical Research Institute
    • Hornik, Chi, Member in the Duke Clinical Research Institute
    • Hornik, Christoph Paul Vincent, Membership in the Duke Clinical Research Institute
    • Husain, Aatif Mairaj, Member of the Duke Clinical Research Institute
    • James, Michael Lucas, Member of the Duke Clinical Research Institute
    • Johnson, F. Reed, Member of the Duke Clinical Research Institute
    • Jones, William Schuyler, Member of the Duke Clinical Research Institute
    • Kamal, Arif H, Member in the Duke Clinical Research Institute
    • Kaye, Deborah R, Member in the Duke Clinical Research Institute
    • Kishnani, Priya Sunil, Member in the Duke Clinical Research Institute
    • Knechtle, Stuart Johnston, Member in the Duke Clinical Research Institute
    • Kollins, Scott Haden, Membership in the Duke Clinical Research Institute
    • Kolls, Bradley Jason, Member of the Duke Clinical Research Institute
    • Kong, David Franklin, Member in the Duke Clinical Research Institute
    • Kosinski, Andrzej Stanislaw, Member in the Duke Clinical Research Institute
    • Kramer, Judith Mae, Member in the Duke Clinical Research Institute
    • Krucoff, Mitchell Wolfe, Member in the Duke Clinical Research Institute
    • Krystal, Andrew Darrell, Member in the Duke Clinical Research Institute
    • Kumar, Karan Ravindra, Member in the Duke Clinical Research Institute
    • Laskowitz, Daniel Todd, Member in the Duke Clinical Research Institute
    • Lee, Kerry L., Member in the Duke Clinical Research Institute
    • Leiman, David Asher, Member of the Duke Clinical Research Institute
    • Lentz, Trevor A., Member in the Duke Clinical Research Institute
    • Li, Jennifer Shiunroh, Member in the Duke Clinical Research Institute
    • Lokhnygina, Yuliya Vladimirovna, Member in the Duke Clinical Research Institute
    • Lopes, Renato Delascio, Member in the Duke Clinical Research Institute
    • Luo, Sheng, Member of the Duke Clinical Research Institute
    • Mark, Daniel Benjamin, Member in the Duke Clinical Research Institute
    • Marsolo, Keith Allen, Member of the Duke Clinical Research Institute
    • Matchar, David Bruce, Member in the Duke Clinical Research Institute
    • Mather III, Richard Charles, Member in the Duke Clinical Research Institute
    • Mathews, Robin, Member in the Duke Clinical Research Institute
    • Matsouaka, Roland Albert, Member of the Duke Clinical Research Institute
    • McCrory, Douglas Charles, Member in the Duke Clinical Research Institute
    • Mehta, Rajendra H., Member in the Duke Clinical Research Institute
    • Mentz, Robert John, Member in the Duke Clinical Research Institute
    • Mitchell, John T, Member of the Duke Clinical Research Institute
    • Muhlbaier, Lawrence H., Member in the Duke Clinical Research Institute
    • Muir, Andrew Joseph, Member in the Duke Clinical Research Institute
    • Myers, Evan Robert, Member in the Duke Clinical Research Institute
    • Naggie, Susanna, Member in the Duke Clinical Research Institute
    • Neely, Megan Lee, Member in the Duke Clinical Research Institute
    • Newby, Laura Kristin, Member in the Duke Clinical Research Institute
    • Newman, Mark Franklin, Member in the Duke Clinical Research Institute
    • O'Brien, Emily, Membership in the Duke Clinical Research Institute
    • O'Brien, Sean Michael, Member in the Duke Clinical Research Institute
    • Ohman, Erik Magnus, Member in the Duke Clinical Research Institute
    • Olsen, Elise Arline, Member in the Duke Clinical Research Institute
    • Onken, Jane Elizabeth, Member in the Duke Clinical Research Institute
    • Ota, David Masao, Member in the Duke Clinical Research Institute
    • Pagidipati, Neha, Member of the Duke Clinical Research Institute
    • Palmer Jr., Scott Michael, Member in the Duke Clinical Research Institute
    • Parikh, Kishan S, Member of the Duke Clinical Research Institute
    • Patel, Keyur, Member in the Duke Clinical Research Institute
    • Patel, Manesh Raman, Member in the Duke Clinical Research Institute
    • Patel, Uptal Dinesh, Member in the Duke Clinical Research Institute
    • Pencina, Michael J, Membership in the Duke Clinical Research Institute
    • Piccini Sr., Jonathan Paul, Member in the Duke Clinical Research Institute
    • Pokorney, Sean, Member of the Duke Clinical Research Institute
    • Povsic, Thomas Joseph, Member in the Duke Clinical Research Institute
    • Pun, Patrick Hank, Member of the Duke Clinical Research Institute
    • Rao, Sunil Vadlakonda, Member in the Duke Clinical Research Institute
    • Reed, Shelby Derene, Member in the Duke Clinical Research Institute
    • Reeve, Bryce B., Member of the Duke Clinical Research Institute
    • Rockhold, Frank Wesley, Member of the Duke Clinical Research Institute
    • Rogers, Joseph G., Member in the Duke Clinical Research Institute
    • Rogers, Joseph G.
    • Rymer, Jennifer Anne, Member in the Duke Clinical Research Institute
    • Scales Jr., Charles Douglas, Membership in the Duke Clinical Research Institute
    • Schanberg, Laura Eve, Member in the Duke Clinical Research Institute
    • Schmidler, Gillian Denise Sanders, Member in the Duke Clinical Research Institute
    • Scialla, Julia Jarrard, Member in the Duke Clinical Research Institute
    • Shah, Bimal Ramesh, Member in the Duke Clinical Research Institute
    • Shah, Svati Hasmukh, Member in the Duke Clinical Research Institute
    • Sikich, Linmarie, Member in the Duke Clinical Research Institute
    • Skinner, Asheley Cockrell, Member of the Duke Clinical Research Institute
    • Smith, Phillip Brian, Member in the Duke Clinical Research Institute
    • Smith, Sophia Kustas, Member in the Duke Clinical Research Institute
    • Snyder, Laurie D., Member in the Duke Clinical Research Institute
    • Sorenson, Corinna, Member in the Duke Clinical Research Institute
    • Sullivan, Daniel Carl, Member in the Duke Clinical Research Institute
    • Sundy, John Sargent, Member in the Duke Clinical Research Institute
    • Swaminathan, Aparna, Member in the Duke Clinical Research Institute
    • Taylor Jr., Donald H., Member of the Duke Clinical Research Institute
    • Thomas, Kevin Lindsey, Member in the Duke Clinical Research Institute
    • Thomas, Laine Elliott, Member in the Duke Clinical Research Institute
    • Todd, Jamie Lynn, Member in the Duke Clinical Research Institute
    • Tucci, Debara Lyn, Member in the Duke Clinical Research Institute
    • Vemulapalli, Sreekanth, Member of the Duke Clinical Research Institute
    • Voora, Deepak, Member of the Center for Applied Genomics & Precision Medicine
    • Walter Jr., Emmanuel Benjamin, Member in the Duke Clinical Research Institute
    • Wang, Tracy Yu-Ping, Member in the Duke Clinical Research Institute
    • Weinfurt, Kevin Phillip, Member in the Duke Clinical Research Institute
    • Welsh-Bohmer, Kathleen Anne, Member in the Duke Clinical Research Institute
    • Wilder, Julius Middleton, Member in the Duke Clinical Research Institute
    • Witsell, David Latham, Member in the Duke Clinical Research Institute
    • Wolf, Myles Selig, Member of the Duke Clinical Research Institute
    • Wong, Charlene, Member in the Duke Clinical Research Institute
    • Wyatt, Christina Marie, Member of the Duke Clinical Research Institute
    • Xian, Ying, Member in the Duke Clinical Research Institute
    • Zafar, Syed Yousuf, Member in the Duke Clinical Research Institute
    • Zimmerman, Kanecia Obie, Membership in the Duke Clinical Research Institute

  • Non-Faculty Positions

    • Chiswell, Karen, Statistical Scientist
    • Hill, Carol, Clinical Trials Project Leader III
    • Overton, Robert, Biostatistician III
    • Xu, Haolin, Biostatistician III
• 

  Administers Grant

  • "CTN-0060: Adolescent Screening and Brief Intervention (ASBI)"
  • "HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis
  • 1/3 Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
  • 2/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)
  • 2/3 Multi-Site - Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
  • 2/5 HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study
  • 3/3 Multi-Site Omega-3 for Co-Morbid Depression & HF Treatment (OCEAN)
  • A Biomarker Study of the APEX-AMI and SOLSTICE Trial Populations
  • A CHF Trial Investigating Outcomes of Exercise Training
  • A Collaboration for Improving Outcomes of African Americans with Heart Failure
  • A Descriptive Study for King Hussein Cancer Center
  • A Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of T3D-959 in Subjects with Mild to Moderate Alzheimer's Disease
  • A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced
  • A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Laboratory Classroom Study with KP415 in Children with Attention-Deficit/Hyperactivity Disorder
  • A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM INVESTIGATIONAL STUDY IN HIGH OR EXTREME RISK PATIENTS WITH SYMPTOMATIC, SEVERE NATIVE AORTIC STENOSIS
  • A Phase 1 Study of AAV8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
  • A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease
  • A Phase 1b MAD Study of TT301/MW189
  • A Phase I Study of the Kappa Opiate Receptor Occupancy and Clinical Mu Opiate Receptor Effects Associated with Repeated Dosing of LY2456302 Trial
  • A Phase III Multi-Center, Randomized, Open-label, Comparative Study to Assess the Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Intravenous Catheter-Associated Bloodstream Infections (BSI) due to Staphylococci
  • A Quality Improvement Approach to the Management of CLL--Research
  • A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke
  • A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus
  • A Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of Escalating Single Doses of ITI-214 in Patients with Systolic Heart Failure
  • A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
  • AASLD Innovation Fund
  • AC220-A-U302 trial
  • ACC Championing Care Registry
  • ACC-NCDR Partnership with Institutional Research Center CATH PCI
  • ACC/Duke Partnership for a National Cardiovascular Research Infrastructure (NCRI)
  • ACE-083_DCRU
  • ACHN-490-007 Trial
  • ACO Model and Comprehensive ESRD Care Initiative
  • ACOSOG Competing Renewal
  • ACOSOG Grant Year 11
  • ACOSOG Supplemental Z1072
  • ACTG A5327 Protocol Chair Support (PCS)
  • ACTG, Aids Clinical Trials Group
  • ACTG, Aids Clinical Trials Group Hepatitis TSG Vice-Chair
  • ACTION EQOL STUDY
  • ACTIV-1
  • ADAPTABLE Supplement
  • AIM BACK UH3 Transition
  • AKL-T01 ADHD Adjunctive
  • AMETHYST Trial Collaboration
  • AMG 986_20150183
  • AMG785-2015242
  • AMGEN - FY21 Think Tank AB
  • ARAMIS Registry (Daiichi Sankyo, Inc.)
  • ARLG
  • ARLG Administrative Supplement
  • ASCVD LEARNING LAB
  • AZ_CLiPPeR: Association of Net Worth with Cardiovascular Outcomes and Medication Adherence in Patients with Acute Myocardial Infarction
  • AZ_CLiPPeR: Educational Background and its Effect on Management and Outcomes in Patients with Acute Coronary Syndromes: Insights from the Linked NCDR Registry ¿ Claims Databases
  • AZ_CLiPPeR: Medication Changes Early after a Myocardial Infarction: Can Patients be Discharged with a 90-day Prescription
  • Abbott Leadless Pacemakers
  • Accelerating Adoption of Comparative Effectiveness Research in Premature Infants
  • Acquisition of FDG PET Registry Data (NOPR Data Audit) 20-DKE-12
  • Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
  • Admin Supplement: Parmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy
  • Administrative Claims-based Efficiencies for the Advancement of Regulatory Sciences
  • Advanced Haplotype Analyses in Coronary Artery Disease
  • Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
  • Aerobic Training During or After Adjuvant Therapy: A Randomized Trial
  • An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis
  • An Innovative Model to Predict Readmissions in Adults with Cardiovascular Disease
  • Analysis of associations between anemia correction in CKD and mortality: CHOIR
  • Anatomic and Physiologic Determinants of Vessel-Specific Ischemia by Coronary CT
  • Anti-psychotic Treatment
  • Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban During Atrial Fibrillation Catheter Ablation: Prospective, Randomised, Open, Blinded Outcome Comparison to Vitamin K Antagonist Therapy
  • Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)
  • Anxiety, Depression, and Non-Cardiac Chest Pain
  • Artemis Supplemental Analysis
  • Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
  • Assessing the Use and Understanding of Certificates of Confidentiality
  • Assessment of Outcomes and Bleeding Complications Following Implantation of DES and DAPT
  • Assessment of a personalized health care intervention for chronic daily headache
  • Assessment of the Number of Patients Treated for In-stent Restenosis using the Duke Health System
  • Association of MitraClip Availability and Hospital Surgical Mitral valve Repair Volume and Mortality
  • Automating Quality and Safety Benchmarking for Children: Meeting the Needs of Health Systems and Patients
  • BCBS/BMP - Subcontract - Technology Assessment - Bone Morphogenetic Protein
  • BEST-VIVA Registry (vCLI)
  • BEST-VIVA Registry (vCLI)
  • BMS Duke Drug Development Series
  • BMS-986231_Heart Failure
  • BRIDGE CCC
  • BRIDGE DCC
  • BUILD
  • Bacteremia Modification 14
  • Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
  • Barriers to Optimal Cardiovascular Medication Use in Diabetes and Renal Disease
  • Baseline Research Consortium
  • Baseline Study
  • Bayer-20115-CONVERT
  • Bayer-21170-RE-THINc
  • Bayesian II (Subproject under TO3 of 290200710066-I)
  • Benefit Risk Tradeoffs Associated with PRO for PAD
  • Best Pharmaceutical for Children Act (BPCA): Use of Meropenem in Infants
  • Beta-Blocker Evaluation Of Survival Trial (Best)
  • Biomarkers of Caloric Restriction in Humans: the CALERIE Biorepository
  • Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
  • Biosensors Registry for BioFreedom Drug Coated Stent (DCS) - LOI
  • Bladder Cancer in Older Adults - Treatment and Outcomes
  • Blood pressure, endothelial cell dysfunction and outcomes in kidney disease
  • Blood-SCAN Feasibility Evaluation, Phase 3
  • Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects
  • Broad-based Support for the DEcIDE Research Network
  • Building UDI Into Longitudinal Data for Medical Device Evaluation (BUILD)
  • Burden of Illness
  • CABANA EQOL Trial
  • CABANA-AF Trial
  • CALERIE
  • CALERIE
  • CALERIE Non-competing Extension with Funds
  • CARRA Accelerating Toward an Evidence Based in Pediatric Rheumatology
  • CARRA Planning Grant-Subcontract to UAB
  • CARRA: Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology
  • CARRA_Cooperative Agreement for Clinical Research in Children with Rheumatic Disaeses
  • CASCADE Registry
  • CAT-HF: Arrhythmias Costs
  • CAT-HF: Biomarkers Costs
  • CBER Study of Adverse Effects in use of TNF Inhibitors
  • CCC: The Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 1/2
  • CD34+ Biologics
  • CEC Activities for BPR-CS-009 Ceftobiprole medocaril
  • CEC Activities for BPR-CS-009 Ceftobiprole medocaril - WO2
  • CEC Adjudications for Lilly GIP_GLP1
  • CEHI Data Management
  • CERT: Risk Series Workshops
  • CERTs Coordinating Center Non-competing Renewal
  • CF-301 Phase III
  • CF-301-102 Study
  • CHAMP-HF
  • CHEER Migraine Study
  • CHS
  • CHS
  • CIAO-ISCHEMIA
  • CIAO-ISCHEMIA
  • CISA
  • CISA TO2 Prophylactic Antipyretics
  • CISA-Task Order 1: Option 1
  • CMS Linkage
  • CMS Linkage in Distributed Data Research Networks - Pilot Project
  • CN-105 Study
  • COMPARE UF
  • COMPARE-UF
  • CONNECT-HF
  • COORDINATE Diabetes Study
  • COVID 19_Protocol Development LOI
  • CPM Analysis
  • CRISP-AMI Data Analysis
  • CSL112_STEMI
  • CSP 442 - #1416
  • CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
  • CTOT Long-Term Extension Study
  • CTTI U19
  • CV Precision Medicine Research Alliance - Governance
  • CVH CRG Program
  • Cancer Tx with a PARP Inhibitor VS Standard
  • Cangrelor in Acute MI: Effectiveness and Outcomes (CAMEO) Registry
  • Cardiac Spectral Analysis (CRDD1008) TO#3-WA3
  • Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study (Yale Subaward)
  • Cardiovascular Cell Therapy Research Network (CCTRN) / CELLVAD-ADRC Protocol
  • Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants
  • Cardiovascular Risk Profile of LAL Deficiency Patients
  • Career Development in Outcomes Assessment in Congenital Heart Surgery
  • Cath PCI Registry 2020 (Amendment 29)
  • Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)
  • Centers for Cardiovascular Outcomes Research
  • Characterization of Lp(a) Testing in a Network Consortium
  • Characterization of Patients with Heart Failure and Patients with Vascular Disease and Atrial Fibrillation in Duke University Health System Data
  • Characterization of Patients with Heart Failure and Patients with Vascular Disease and Atrial Fibrillation in PCORnet Data
  • Chest Pain MI Registry CO#20
  • Claret Sentinel System Statistical Analysis
  • Clinical Pharmacokinetics and Safety Trials in Down Syndrome
  • Clinical Phenotypes and Outcomes Associated with Tricuspid Regurgitation
  • Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification
  • Clinical Predictors of Antiretroviral Failure
  • Clinical Trial Services Agreement with bioCSL to Study the Performance of CSL Trivalent Influenza Vaccine
  • Closing the Quality Gap Series: Revisiting the State of the Science - "Medical Home"
  • ClotChip
  • Collaboration between Duke University and the NIAID
  • Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions
  • Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions
  • Collaboratory Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) (U24)
  • Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE)
  • Comparative Effectiveness Reveiws for MMA Section 1013
  • Comparative Effectiveness Reviews for MMA Section 1013
  • Comparative Effectiveness of CARRA Treatment Strategies for Polyarticular Juvenile Idiopathic Arthritis
  • Comparative Effectiveness of Left Atrial Appendage Closure versus Under-dosed Anticoagulation for Patients with Non-Valvular Atrial Fibrillation
  • Comparative Effectiveness of Medications Used in Congenital Heart Surgery
  • Comparative Effectiveness of Therapies for Heart Failure
  • Comparative effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
  • Comparison of Methotrexate and Biologics in JIA (COMPARE-JIA)
  • Comprehensive EPC Comparative Effectiveness Reviews for Effective Health Care
  • Computer-based guidelines to prevent sudden cardiac death
  • Congestive Heart Failure Device
  • Considering Patient Preferences in Chronic Cough
  • Consultation for the Stanford Microbiome Therapies Initiative
  • Cooperative Multi-Center Reproductive Medicine Network
  • Coordinating Center for CERTs
  • Coordinating Center for DILIN
  • Coordinating Center for the Drug Induced Liver Injury Network (DILIN) - Competitive Renewal
  • Coordinating Center for the Drug Induced Liver Injury Network (DILIN) - Competitive Renewal
  • Coordinating Center for the Drug Induced Liver Injury Network (DILIN)- Supplement
  • Core variable Assessment Towards a NatIonal evaluation Program (CATNIP) - Subcontract with Weill Cornell
  • Creating a Pulmonary Fibrosis Foundation Patient Registry and Care Center Network
  • Creating the Learning Healthcare Platform of the Future: High Risk ASCVD Registry for Longitudinal follow up
  • Creating, Implementing, and Sharing Best Practices for Clinical Trials Networks
  • Creation and demonstration of a palliative care research cooperative group
  • DAP Phase I PK/PD Analysis Budget
  • DCC: Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 2/2
  • DCRI CARRA Registry
  • DCRI CERT for Cardiovascular Therapies
  • DCRI HCP Advisory Board Council
  • DCRI Research Center for CERTs
  • DCRI Think Tank
  • DCRI Think Tank
  • DCRI Think Tank
  • DCRI Think Tank
  • DCRI Think Tank
  • DCRI Think Tank
  • DCRI Think Tank-BI
  • DCRI Think Tank-Eli Lilly
  • DCRI Think Tank-Sanofi
  • DCRI-Stanford CEC Summit
  • DCRI-Stanford CEC Summit
  • DCRI-Stanford Symposium
  • DCRI-Stanford Symposium
  • DE40 Xeries XSGR-PBH-201
  • DECIDE 2
  • DEFINE-PCI
  • DELIVER HF EHR SCREENING INITIATIVE
  • DEcIDE AVR
  • DEcIDE DES TO4 W3
  • DEcIDE Health Outcomes of Carotid Artery Disease
  • DEcIDE Stents TO4 WA2
  • DG29 SERES
  • DN44 Acceleron extension
  • DRI13940 Study
  • Data Characterization of DUHS data for Amgen project
  • Data Coordinating Center For Scd In Heart Failure Trial
  • Data and Statistics Center for the Clinical Trials Network
  • Decide 2 Administrative Task Order for Travel to AHRQ
  • Decision Making by Patients Seeking Care for Fertility Problems
  • Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
  • Development of national registry for patients receiving primary care in the home
  • Dialysis Facility Management
  • Direct Administration of AdVEGF-All6A+ LOI
  • Disease Recapture After Drug Discontinuation and Flare in JIA
  • Duke Administrative Work Assignment - ADMD0508 - TO#3-WA5
  • Duke Cardiovascular CERTs
  • Duke Summer Training in Academic Research (Duke's STAR)
  • Duke-UNC Sickle Cell Disease Clinical Research Network
  • Dupilumab Food Allergy Program
  • Dupilumab Food Allergy Program
  • Dyanavel Efficacy Study
  • Dyanavel Safety Study
  • Dynamic Outcomes Assessment in Multi-Center Trials
  • ECHO Administrative Supplement - Neonatal Opioid Exposures
  • ECHO Coordinating Center
  • EEG Coordinating Center
  • EFC 13794
  • EGFR Testing Patterns and Outcomes in Non-Small Cell Lung Cancer in the VA Health System
  • EMPA MI Jardiance®, empagliflozin
  • EMPA-KIDNEY Trial
  • ENDOMAX CEC and DSMB
  • EPC Project: ECG Update
  • EPC Project: Medical Test Guide
  • EPC Project: Medical Test Guide (2nd phase)
  • EPC Project: Medical Test Guides - training modules
  • EPC Project: Mental Health
  • EPC Technical Support of the Technology Assessment Program 75X1700 8-K720001 25505
  • EPC V Admin Task TO1- Admin Task-Methods and Dissemination: Collaboration to improve validity, consistency, and utility of systematic reviews
  • EPC _TO #1_WA #3_Anemia Management in Renal Disease Populations - (Part 1)
  • EPC: Postpartum Depression
  • EPC_TO#2_WA#3_Comparative Effectivness of ACEIs and ARBs foor Treating Essential Hypertension
  • EPC_TO#3_WA#7_Anemia Management in Renal Disease Populations - Part 2
  • ESCAPE - Evaluation Study of Congestive Heart Failure and Pulmonary Artery Cathetorization Effectiveness
  • ESCAPE Mechanistic Substudy Grant Application
  • Early Diagnosis of Neonatal Candidiasis
  • Echocardiogram to Diagnose Pulmonary Hypertension in Premature Infants
  • Economic Analysis for the ATlantic C-PORT Trial
  • Economics and Quality of Life in OAT
  • Economics and Quality of Life in SCD HEFT
  • Educational Videos to Reduce Racial Disparities in ICD therapy Via Innovative Designs (VIVID)
  • Effectiveness of disease-modifying anti-rheumatic drugs (DMARDs) in children with juvenile idiopathic arthritis (JIA)
  • Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of the CNS
  • Efficiencies for Outcome Ascertainment throughout the Total Product Life Cycle
  • Electronic Knowledge Management and Clinical Decision Support-TO5
  • Enabling Real-time, Personalized Engagement in Research: an App-based Approach
  • Engaging patients, community, and health system stakeholders to establish PCOR priorities
  • Engaging, Inspiring, and Preparing the Next Generation of Biostatisticians
  • Enhancing CARRA Research: Integration and Dissemination of Clinical Data
  • Enhancing the U.S. Public Health System's Willingness and Capacity to Engage in Clinical Research
  • Eosinophilic Esophagitis (EoE)
  • Epilepticus_EEG Coordinating Ctr.
  • Establishment and Maintenance of the Innovation Center
  • Ethical Approaches to Genotype-Driven Research Recruitment
  • Ethical Approaches to Research Use of Clinical Records and Data
  • Evaluating and Improving Cardiac Arrest Resuscitation Efforts in Hemodialysis Clinics
  • Evaluating fitness-for-use of Electronic Health Records in Clinical Research
  • Expanding HL7 FHIR to support post-marketing research and surveillance within multi-source, chronic disease registries
  • Exscel Biomarker Analysis and Secondary Manuscript Production
  • Extraction Vs Capping Pacing and Defibrillator Leads
  • FAST- MAS Administrative Task Year 2
  • FAST- MAS Administrative Task Year 3
  • FDA Crusade Database Query
  • Fast-Fail Trials in Mood and Anxiety Spectrum Disorders (FAST-MAS)
  • Financial Assistance, Navigation, and Communication Education (FinANCE): Development and pilot testing of a web-based financial toxicity intervention
  • Financial and Social Behavioral Economic Incentives to Increase Physical Activity in Adolescents and Young Adults for Cardiovascular Health
  • Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research
  • Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research Option Period 3
  • Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research- Option 1
  • Fitness-for-Use of Electronic Health Records as Source Data for Clinical Research- Option 2
  • Framingham Study - Amendment 3
  • From Clinic to Community: Achieving Health Equity in the Southern United States
  • GARFIELD-Atrial Fibrillation Registry Research
  • GBGJ Dulaglutide_CEC
  • GDF-15 FIGHT/RD003507
  • GSK-CKD program_CEC
  • GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
  • GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
  • GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)
  • Gene Therapy 4D-310 in Adult Males with Fabry Disease
  • General DEcIDE Network Support: Methods and Dissemination
  • General EPC Support: Methods and Dissemination
  • Get With The Guidelines AHA Measure Reliability Testing SOW #18
  • Gilead GS-US-334-0107 LOI
  • Global Pediatric Clinical Trials Network
  • Guiding Evidence Based Therapy Using Biomarker Intensified Treatment (EQOL)
  • H9X-MC-GBGL
  • H9X-MC-GBGO
  • HCM Video Development project
  • HCQ Pharmacokinetics in Pediatric Lupus
  • HCV/HIV Co-infection Registry
  • HERO Program, HERO Registry, HERO-HCQ Trial
  • HF Action Supplement
  • HFN / HIV Supplement
  • HFN LIFE Industry Supplemental Funding
  • HO-15-16139: Clinical, Epidemiological, and Health Economic Characteristics of Acute Decompensated Heart Failure Patients with Varying Degrees of Respiratory Involvement
  • HUMAN USE CONDITION STUDY ASSOCIATION FOR ADVANCEMENT OF MEDICAL INSTRUMENTATION FLUOROSCOPIC EVALUATION OF 3D CURVATURE OF IMPLANTED LEADS IN HUMANS
  • Health Care Systems Research Collaboratory - Coordinating Center
  • Heart Failure : Epidemiology & Outcomes in the Elderly
  • Heart Failure Clinical Research Network - DCC
  • Heart Failure Network: Year 12 Non-Compete Renewal
  • Heart Rescue Flagship Premier Partner Program "RACE CARs"
  • Heart/Lung Transplant Study
  • HeartRescue
  • HeartRescue
  • HeartRescue Brazil (RAPIDO)
  • Hypericum Perforatum In Depressive Disorder, Coordinating
  • Hyperinsulimia and Insulin Resistance in Nonalcoholic Fatty Liver Disease
  • ICD Therapy in Patients with Congestive Heart Failure
  • ID-076A301; SOS-AMI; Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of subcutaneous self-administration of selatogrel for preventi
  • IMPACCT
  • IMPROVE STROKE
  • IMPROVE Stroke Care Systems of Care Research Program
  • INSPIRE
  • IPA - Mary Elizabeth Wing
  • IPA - Mary Elizabeth Wing
  • IPA - Patricia Cowper
  • IPA - Patricia Cowper
  • IPA - Remy Coeytaux
  • IPA-Mary Liz Wing
  • IPA-Robyn Schmidt
  • IPA-VA Palo Alto OPTIMA
  • IPF Wrap
  • ISCHEMIA-CKD SDCC
  • ITI Parkinson's Disease Study
  • ITI-214-104
  • IW-1973 Caplet
  • Idiopathic Pulmonary Fibrosis Clinical Research Network
  • Idiopathic Pulmonary Fibrosis Clinical Research Network
  • Idiopathic Pulmonary Fibrosis Clinical Research Network NCE
  • Immunoglobulin Therapies Based on Treatment Experience
  • Immunological biomarker studies in myasthenia gravis
  • Impact of early discharge following bypass surgery
  • Implementation of Demonstration Project for Health Systems: Atrial Fibrillation(INFORM-AF)
  • Implementing Research Findings for Practice Improvement
  • Improvement of interoperability of healthcare data
  • Improving Data Completeness and Expanding Available Data Elements in the TVT Registry through the use of Electronic Health Record Based Data: Linking the TVT Registry and PCORnet
  • Improving Methods for Comparative Effectiveness Research in Cardiovascular Care
  • Improving Outcomes in Limited Juvenile Idiopathic Arthritis
  • Improving stroke risk prediction with cohort data and machine learning methods
  • Increasing Patient and System Value with Community Based Palliative Care
  • Increasing Patient and System Value with Community Based Palliative Care
  • Increasing the Quality and Efficiency of Clinical Trials (U18)
  • Indiana University Intramural Grant - Echocardiographic Image Analysis
  • Indiana University Intramural Grant - Genetic Biorepsitory
  • Inflammation & Prognosis in Decompensated Heart Failure
  • Inhalant Use/Dependence: Incidence and Co-Morbidity
  • Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects with Known Lambert-Eaton Myasthenic Syndrome (LEMS) [JPC 3,4-DAPPER]
  • Integrating Palliative Care in Oncology Practice
  • Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levels
  • JTT-251_HF Trial
  • Jackson Heart Study
  • Janssen AF Quality Improvement Research Study
  • Janssen HERO Vaccine Trial Start Up Budget
  • Janssen TIDM Diabetes Study
  • KOR Phase 2A Study - Mod 3 (Advanced Understanding)
  • LEADER Trial: Association between weight change and cardiometabolic risk factors in a real-world population of U.S. Adults
  • Leadership and Operations Center (LOC) AIDS Clinical Trials Group (ACTG) Protocol Chair Support for A5380
  • Leadership and Operations Center (LOC), Aids Clinical Trial Group (ACTG) HEP Committee Chair
  • Leslie Walker IPA (VA-funded project IIR #05-273-2 )
  • Leveraging Real World Evidence to Understand Contemporary Medical and Surgical Care
  • Leveraging registry resources for efficient and cost effective clinical trials
  • Li Lin support from MCW
  • Lilly GPGB Diabetes Study
  • Linking Safety Practices to Adverse Events and Outcomes in Hospitalized Infants
  • Lung Microbiome Study in IPF
  • Lung Microbiome Study in IPF
  • Lung Repair and Regeneration Consortium Administrative Coordinating Center
  • MACE COMMITTEE COLLABORATION LOI
  • MDEpiNet J&J Dues
  • MDEpinNet: RAPID Phase II
  • MEDpiNET: Industry Funding
  • MESA
  • MESA
  • MG 302 Extension (RAISE XT)
  • MITRAL Trial
  • MOM-M281-004
  • MOM-M281-005
  • MOST Administrative Statistical Support
  • MYK-461-004: Phase 2a and 2b Program
  • Major Depression with Suicidal Ideation
  • Malaria chemoprevention in children with sickle cell anemia in Western Kenya
  • Managed Care Features Affecting Quality for CAD Patients
  • Managing the Risks of Therapeutic Products
  • Managing the Risks of Therapeutic Products, January 12-14, 2003.
  • Mapping Quality in the Stroke System of Care: Do hospitals that share in the care of Acute Stroke patients also share
  • Marital Trajectories and Cardiovascular Disease in the United States
  • Master Plan for Integration of Innovation Technologies and IC Collaboration Activities
  • Mechanisms of Hormone Therapy in Post-Menopausal Women
  • Medtronic Stroke Initiative
  • Meningitis B Vaccine European study
  • Mentoring in Clinical Pharmacology and Early Phase Trials
  • Mentorship of early-career pediatricians in quantitative methods and therapeutics
  • Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)
  • Methodology for Linking Clinical and Administrative Databases
  • Methods and Dissemination
  • Mission Lifeline Texas State System Report
  • Mission Lifeline Texas State System Report
  • MitraClip Procedure versus Surgery
  • Mod 11 for Option 3 - Staphylococcal Bacteremia Study
  • Modification No 13 Staphylococcal Bacteremia Study
  • Modification No. 5 - Staphylococcal Bacteremia Study
  • Modification No. 8 - Staphylococcal Bacteremia Study
  • Modified KOR Phase 2A Study
  • Molecular Atlas of Lung Development - Data Coordinating Center
  • Moving Towards More Individualized Therapies in HIV/HCV Co-infected Patients
  • MyoKardia HCM App
  • Myocardial Ischemia and Transfusion (MINT) Steering Committee
  • NCDR-ACTION
  • NCDR-ACTION Patient Navigator
  • NESTcc Data Quality Committee
  • NIA AD/ADRD Health Care Systems Research Collaboratory
  • NIDCD R21/R33 Phased Infrastructure Grant for Patient-Oriented Research
  • NIDCD R21/R33 Phased Infrastructure Grant for Patient-Oriented Research
  • NIH Health Care Systems Research Collaboratory - Coordinating Center
  • NIH Health Care Systems Research Collaboratory - Coordinating Center
  • NIH Single Instiutional Review Board (sIRB)
  • NIH State of the Science Conference on Preventing Alzheimer's Disease and Cognitive Decline
  • NIH Summer Research Experience Programs (R25)
  • NLM Lab Query
  • NRSA Training Grant for Clinical Pharmacology - Dallefeld and Chaparro
  • National Drug Abuse Treatment Clinical Trials Network
  • National Longitudinal Outcomes Following Surgical Therapy for Lung Cancer
  • National Surveillance of Stroke Outcomes and Quality of Care using the Get With the Guidelines(GWTG) Stroke Registry
  • National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer and its Effect on Health Disparities, Chemotherapy Utilization, and Associated Costs
  • National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer and its Effect on Health Disparities, Chemotherapy Utilization, and Associated Costs
  • Nationwide Utilization of Cardiac Imaging In Cancer Patients
  • NeSTcc Test Case 6 Johnson and Johnson Certus device
  • Nitroprusside in Children (NITPIC)
  • North Carolina Collaborative PPRU Network
  • North Carolina Congenital Heart Defects Surveillance Network
  • ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment with Alirocumab
  • ODYSSEY RCC
  • OPTIMIZE
  • ORBIT AF
  • Odyssey RCC
  • Omecamtiv Mecarbil in Heart Failure
  • Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients with Invasive Fungal Infections that are Refractory to or Intolerant of Standard Antifungal Treatment (FURII)
  • Operationalizing Patient-Reported Outcomes Measurement with Electronic Health Records in Patients with Heart Failure
  • Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis
  • Optimizing Health Outcomes in Patients with Symptomatic Aortic Valve Disease
  • Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery
  • Optimizing anticoagulation dosing and adherence for patients with non-valvular atrial fibrillation (ARISTA)
  • Optimizing duration of antibiotics after valve surgery for infective endocarditis
  • Optimizing the Electronic Health Record for Cardiac Care
  • Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin
  • Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
  • Oral Doses of MYK-491 in Patients with Stable Heart Failure
  • Overcoming barriers to addressing childhood opioid exposure: Developing Standard Clinical Outcome Assessments for Pediatric Trials of Opioid-Sparing Drugs for Acute Pain
  • P1CTU_Task Order 16_Protocol Development
  • P1CTU_Task Order 16_Protocol Implementation
  • PACTTE-Partnership for Anemia: Clinical and Translational Trials in the Elderly
  • PAH trial of GB002
  • PAH_POC
  • PARADISE
  • PARTNERS
  • PARTNERS Extension
  • PCI QA Review
  • PCORI Short Term Communications Procurement Plan
  • PCORI_Triage and FR Prioritization - Amendment #3
  • PCORI_Triage and FR Prioritization - Amendment #4
  • PCORNet Communications - Engagement Materials
  • PCORnet Phase II Rapid Research TO#13 Mod 2
  • PCORnet Phase II TO#15
  • PCORnet Phase II TO#17- DCRI Leadership
  • PCORnet Phase II TO#18- HPHC Leadership
  • PCORnet Phase II TO#19- DCRI DRN
  • PCORnet Phase II TO#20- HPHC DRN
  • PCORnet TO#16- Privacy-Preserving Record Linkages (PPRL)
  • PCORnet TO#7 Planning Project with Genetic Alliance
  • PDE-1 Inhibitor Study- LOI
  • PMR 292932: A Nationally Representative Drug Utilization Study of OxyContin in Children Aged 17 Years and Younger
  • POC 2-D Diffusion Assay for self-monitoring of BNP
  • POPS Lab
  • PRA-Ionis ATTR-CM
  • PRECISE
  • PREMIS: Preventive Misconception in HIV Prevention Trials
  • PROACT II - Prospective Randomized On-X Anticoagulation Clinical Trial
  • PROMISE Substudy to Assess For Effective dose of Radiation (PROMISE-SAFER)
  • PROMISE Trial: Clinical Coordinating Center
  • PROMISE Trial: EQOL Coordinating Center
  • PROMISE Trial: SDCC
  • PROVIDE-HF: Patient Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (Valsartan/Sacubitril) in Heart Failure.
  • PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
  • PTN 2.0 TO 1 Core Function Activities_Option 2
  • PTN 2.0 TO 5 Modification
  • PTN 2.0 TO 6 Down Syndrome Extension
  • PTN 2.0 Task Order 7 HIV Lactation
  • PTN 2.0- TO 3 - Option 2 - BPCA Concept Development and Clinical Trial Readiness Support
  • PTN 2.0: Task order #2 COVID-19 POP02
  • PTN POPS III
  • PTN TO #21- Pharmacokinetics of Multiple Dose Methadone in Children
  • PTN TO #25 SCAMP
  • PTN TO #30 POPS Lab Mod. 2
  • PTN TO #34: Program Management Support
  • PTN TO #34: Program Management Support - Option 2
  • PTN TO #34: Program Management Support - Option 2 Mod 1 (Mod 4)
  • PTN TO #39: PPE
  • PTN TO #41: Sildenafil II
  • PTN TO 22-Bronchopulmonary Dysplasia (BPD) and the Use of Diuretics in the NICU
  • PTN TO 23-The Effect of Obesity on the Pharmacokinetics of Pantoprazole in Children
  • PTN TO# 35 Furosemide II
  • PTN TO# Anesthesia
  • PTN TO#14 (Mod #3) - Efficacy of sildenafil in premature infants with Pulmonary Hypertension
  • PTN TO#36 - PTN Repository
  • PTN TO#37 Efficacy, Pharmacokinetics, and Safety of Topical Timolol in Infants
  • PTN TO#37 Obesity CNS PK Trial
  • PTN TO#38 Efficacy, Pharmacokinetics, and Safety of Topical Timolol in Infants
  • PTN TO#40 (Protocol Development IV)
  • PTN TO#42 HAP
  • PTN TO#42 HAP - Modification #1
  • PTN TO#44 Baby Mercy Tape II (TAP03)
  • PTN TO#47 (Protocol Development V)
  • PTN TO48 - Pharmacokinetics of Anesthetics and Analgesics in Children and Adolescents Extension
  • PTN TO: BPCA INNOVATIVE TRIAL DESIGNS FOR DOSING, SAFETY, and EFFICACY in PEDIATRIC THERAPEUTICS
  • PTN Task Order #10: Ampicillin
  • PTN Task Order #11: Obesity Informatics Database
  • PTN Task Order #12 Protocol Development (RFTOPs)
  • PTN Task Order #13: Pharmacokinetics of Antistaphylococcal Antibiotics in Infants
  • PTN Task Order #14: Sildenafil study
  • PTN Task Order #15: Fluconazole Safety Trials
  • PTN Task Order #16: Pediatrix Safety Study
  • PTN Task Order #17: Bioanalytical Analysis: POPS1, Fluconazole, and Meropenem
  • PTN Task Order #19: Lorazepam
  • PTN Task Order #20: POPS II
  • PTN Task Order #24: Protocol Development II
  • PTN Task Order #28 Baby Tape
  • PTN Task Order #3 - Safety and Pharmacokinetics of Multiple Dose Metronidazole in Premature Infants
  • PTN Task Order #4: Hydroxyurea PK
  • PTN Task Order #5: Acyclovir
  • PTN Task Order #6: Opportunistic Studies
  • PTN Task Order #7: Lisinopril
  • PTN Task Order #8: TAPE
  • PTN Task Order #9: Midazolam
  • PTN Task Order 25 SCAMP Modification
  • PTN Task Order 29: Clindamycin Bactrim
  • PTN Task Order 34 - Program Management Support
  • PTN Task Order 36- PTN Repository: Modification 1
  • PTN Task Order 8 COVID-19 Studies
  • PTN Task Order--Protocol Development III
  • PTN Task Order: CAFFEINE
  • PTN Task Order: Safety of Furosemide in Premature Infants
  • PTN2- TO# 3 Concept Development and Clinical Trial Readiness Support Option Period 1
  • PTN2- TO# BPCA Concept Development and Clinical Trial Readiness Support
  • PTN2- TO# BPCA Pharmacology Studies
  • PTN2- TO# Data Closeout and Dissemination
  • PTN2- TO#4 Data Closeout and Dissemination Option Period I
  • PTN_TO#50 POPS LAB
  • Palliative Care for High-Risk TAVR Patients: The Impact of Multimorbidity
  • Palliative Care in Heart Failure (PAL-HF)
  • Panachen 17582
  • Pantheon 15128
  • Pass-Through cost- CLIN04
  • Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
  • Patient Preference Information: Bridging Regulatory Decisions and Clinical Practice
  • Patient Preferences in the Treatment of Diffuse Large B-cell Lymphoma
  • Patient Valued Comparative Effectiveness of Corticosteroids Versus Anti-TF Alpha Therapy
  • Patient preferences targeting PCSK9 protein
  • Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research
  • Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research
  • Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF
  • Pediatric Crohn's Disease Patient and Provider Risk-Benefit Preferences for Monotherapy versus Combination Therapy
  • Pediatric Trials Network
  • Pediatric Trials Network_ Task Order 1_ Core Function Activities
  • Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1
  • Percutaneous Heart Valve Replacement - HEVA0608
  • Perinatal Quality Collaborative of North Carolina Statistical Support
  • Ph3 ATTR Cardiomyopathy Study
  • Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants
  • Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass
  • Phase 1 - The Effectiveness of Disease-modifying Anti-rheumatic Drugs in Children with Juvenile Idiopathic Arthritis
  • Phase 1 Clinical Trials for Development of Neurotherapeutics Performance
  • Phase 1 single-ascending dose study of the safety and pharmacokinetics of 24 hour intravenous 5-HTP (EVX-301)
  • Phase 2 - The Effectiveness of Disease-Modifying Anti-Rheumatic Drugs in Children with Juvenile Idiopathic Arthritis
  • Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development
  • Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development, Year 3
  • Phase I MAD Study of JNJ-55920839
  • Physiologically Based Pharmacokinetics in Critically Ill Children
  • Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
  • Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children
  • Pilot Project applying the National Clinical Research Associates model within the Duke Translational Medicine Institute
  • Platform for Engaging Everyone Responsibility (PEER) Validation
  • Pneumonia LOI
  • Postdoctoral Training in Cardiovascular Clinical Research
  • Postmarketing Assessments of Pharmaceutical Risk
  • Power of Bayesian Methods, RCTs, and Decision Models to Inform CRT Uncertainties
  • Preference Studies in Alzheimer's Disease: General Population Surveys
  • Preference Tx for Sequencing in NSCLC
  • Premier IPF_2
  • Preschool Vision Screening in Primary Care Settings
  • Preventing Cardiovascular Disease through Improved Risk Prediction and Communication
  • Preventing Sudden Cardiac Death: Harnessing the Power of Decision Analysis, Bayesian Techniques, and Clinical Trials
  • Prevention of Cardiovascular Complications of Pediatric SLE
  • Prevention of Influenza in Infants by Immunization of Their Contacts in the Household (PIIITCH study)
  • Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes
  • Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes
  • Procyrion FIM Device Study
  • Prognostic Discordance in Oncology: what's behind the misunderstanding?
  • Prognostic value of Heart Rate Variability measured by Cardiovascular Implantable Electronic Devices
  • Prospect of Direct Benefit in Pediatric Reseach in Type 1 Diabetes (T1D)
  • Prospective Comparison of Colonic Imaging Tests
  • Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
  • Protocol CNTO1275CRD3007
  • QT prolonging medications and sudden cardiac death among individuals on hemodialysis
  • Quality of Care and Resource Utilization in Apparent Treatment Resistant Hypertension
  • Quatifying Patient Preferences for Heart Failure Interventions
  • R21 ICT Tools for Rare Diseases
  • RADx-UP CDCC
  • RAISE
  • RARE DISEASE NETWORK FOR MYASTHENIA GRAVIS
  • REHAB HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
  • REMOTE HF-ACTION
  • RESULT Trial-REflux SUrgery in Lung Transplantation
  • REVEAL (Reduction of Infarct Expansion & Ventricular remodeling with Epo Admin after Large MI)
  • ROBUST METHODS FOR THE EFFICIENT ANALYSIS AND INTEGRATION OF DNA SEQUENCE DATA
  • RTI-TO2-Newborn Screening Pilot Study for Adrenoleukodystrophy (ALD)
  • RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study
  • Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
  • Real World Assessment of Vascular Device Safety and Effectiveness
  • Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer
  • Reflexion Virtual Rehab Study
  • Regional Systems Accelerator: Implementation of the AHA Mission (TMC)
  • Registry on cost per disability-adjusted life year (DALY) studies
  • Relationship between cerebrospinal fluid penetration of antimicrobials in infants and juvenile animals
  • Rescuing Kidneys at Risk of Discard
  • Resources for Mentorship of Clinician Scientists in Hearing and Balance Disorders
  • Retrospective QTc Analysis for PER977-01-001
  • Rheumatoid Arthritis ABBV-3373
  • Risk Prediction for Secondary Events in Adults with Arteriosclerotic Cardiovascular Disease (ASCVD)
  • Risk prediction for S Arteriosclerotic Cardiovascular Disease (ASCVD) in persons on statins
  • Risk stratification using genetic and microbial determinants in childhood onset RA
  • Role of CD4 T cell subsets as drivers of MG disease
  • Role of pharmacokinetics and genomics in tocolytic therapy with indomethacin (subcontract)
  • SAFE STEMI in Seniors LOI for Volcano
  • SAFE-PCI for Women: FDA
  • SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg
  • SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg
  • SOFTAD-Substance use outcomes following treatment adolescent depression
  • SOLI - Solithromycin Pediatric Development Program (Phase 2/3 start up)- MOD 2
  • SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost
  • SOLI - Solithromycin Pediatric Development Program (Phase IB)- MOD 2
  • SPIRRIT - DCC
  • SPIRRIT-HFPEF - CCC
  • STICH Statistics and Data Coordinating Center
  • STICH Trial - Coordinating Center
  • STICH Trial-Economics & Quality of Life Core Laboratory
  • STICHES
  • Safer Antithrombotic Therapy for Elderly ACS Patients
  • Safety and Effectiveness of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer
  • Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia
  • Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
  • Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
  • Sanofi SOTA Outcomes EFC15156
  • Sentinel Innovation Center WO#2
  • Solicitation APP 111513, Hospital Engagement Contractor
  • Southern Consortium Node of the Clinical Trials Network
  • Spoonfulone
  • Stage III NSCLC in the VA Health System
  • Stakeholder Support and Meetings for the DEcIDE Cardiovascular Consortium
  • Standardized Collection and Submission of Cardiovascular Endpoint Data
  • Standardizing and Optimizing Childhood Lupus Nephritis Treatment through CARRA
  • Stated Therapy Preferences of Child Caregivers and Adult Patients with Peanut Allergy
  • Stated-Preferences in Knee Arthroplasty
  • Study Network of Acinetobacter as a XDR pathogen (SNAP)
  • Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF
  • Study to Evaulate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry.
  • Subcontract to UNC: UNC Research Centers for Excellence in Clinical Preventive Services
  • Subcontract: Comparing Traditional and Participatory Dissemination of a Shared Decision Making Intervention
  • Subcontract: Epidemiological and Behavioral Research in Oral Health
  • Subcontract: Epidemiological and Behavioral Research in Oral Health
  • Support for Specimen Banking in ACOSOG GY 6
  • Symptoms of Lower Urinary Tract Dysfunction Research Network (U01) Supplement
  • Synthetic Control Arm for IPF
  • TASK AREA A TASK ORDER FY.2016.A1.0041
  • TNBC Study
  • TO # 1 - Coordinating Center for Cardiovascular Disease
  • TO # 1 - Coordinating Center for Cardiovascular Disease - OPTION YEAR 2
  • TO#4 CC Leadership
  • TRANSFORM-HF CCC
  • TRANSFORM-HF CCC (Subcontract with Yale)
  • TRANSFORM-HF DCC
  • TRC-THD Administrative Coordinating Center (ACC)
  • Targeted discovery longitudinal proteomics to understand the systems biology difference of furosemide vs. torsemide for patients with heart failure: An ancillary study of TRANSFORM-HF
  • Task Order 1: CC Phase II Master Contract Leadership
  • Task Order 7: Front Door
  • The Aga Khan University-Pakistan Initiative for NCDs (AKUPI-NCDs)
  • The Congenital Heart Technical Skill Study: Improving Outcomes for Infants and Children with Congenital Heart Disease
  • The Data FITS Study of EHR-to-EDC eSource Data Collection
  • The ISCHEMIA Trial - EQOL
  • The ISCHEMIA Trial - SDCC
  • The ISCHEMIA Trial - SDCC
  • The ISCHEMIA Trial - SDCC- Subcontract with NYU
  • The Impact of Quality Metrics on Outcomes among Elderly Heart Failure Patients
  • The Jahnigen Career Development Award (JCDA)
  • The Lung Transplant Clinical Trials Network (LT-CTN)
  • The NAD+ Baseline Study
  • The North Carolina Congenital Heart Disease Surveillance Network
  • The Pharmacokinetics of Extended Duration High-dose Cefixime Co-administered with Azithromycin for the Decreased Susceptibility of Neisseria gonorrhoeae: A Phase I Pilot Study
  • The Pharmacokinetics of Extended Duration High-dose Cefixime Co-administered with Azithromycin for the Decreased Susceptibility of Neisseria gonorrhoeae: A Phase I Pilot Study, Option 1
  • The Project Baseline Community Study (#101143)
  • The Southern Consortium Node of the Clinical Trials Network
  • Thrombolysis in Ischemic Stroke Patients: Recent Stroke,AM Infarction,Major Surgery, Combo Prev Stroke Diabetes Mellitus
  • Thyrogen Utilization Patterns in the Treatment of Thyroid Cancer
  • Tools for Economic Analysis of Patient Management Interventions in Heart Failure
  • Topic Briefs TO#4_Disease Modifying Therapies on Multiple Sclerosis
  • Topic Refinement 2015
  • Topic Refinement 2015
  • Topic Refinement, Task order 8 PCSK9
  • Topic Refinement, Task order 9 Topic Briefs
  • Towards an Understanding of the Pathophysiology and Clinical Outcomes of Patients w/Endocarditis
  • Training for Clinical Research in Hearing Balance and Other Communication Disorders
  • Transition of Care for Acute Stroke and Myocardial Infarction Patients
  • Translating CER results from ICU study to improve outcomes in cardiac surgery NCE
  • Treating Pain in Fibromyalgia
  • Treatment Switching Behavior among Multiple Myeloma Patients
  • Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center
  • Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center
  • Trial to Assess the Effects of Medication Therapy Managment
  • UAMS Subcontract_IDeA States Mentorship
  • UCB Patient Insights Project
  • UCB-UNC Fellowship in Neurology Clinical Drug Development
  • UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
  • UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
  • UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
  • Understanding Patient Expectations of Treatment Outcomes
  • Understanding Quality and Costs in Congenital Heart Surgery
  • Urinary Dysfunction in the Elderly: Informing Accountable Urologic Care
  • Urinary Stone Disease Research Network: Scientific Data Research Center
  • Using AACT - to answer Oncology landscape portfolio of open trials
  • Using PCORnet to Compare Blood Pressure Control Strategies (Subaward to UCSF)
  • Using the NIH Collaboratory Distributed Research Network to Identify and Characterize ADRD patients
  • VA IPA for Yanhong Li
  • VA Merit Grant- IPA Agreement
  • VA Net, Coordinating and Operations Research Center
  • VAC057: Assess the reactogenicity, safety, and immunogenicity of a live attenuated universal influenza vaccine
  • VICTORIA Registry
  • VITALITY
  • Vaccine Trial_LOI
  • Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
  • Value of Information Analysis: PCORnet Aspirin Maintenance Doseage Trial
  • Variability, Medical Therapy, and Outcomes in Patients with Peripheral Artery Disease Who Undergo Lower Extremity Endovascular Revascularization Procedures
  • Variation in Human Platelet Function: PAR4 Functional Genomics
  • Vascular Protection Initiative
  • Vericiguat VICTORIA
  • Vesalius Real Registry
  • Victoria Econ
  • Vitamin D Supplementation in Children with Obesity-Related Asthma (VDORA1)
  • Warfarin versus Direct Oral Anticoagulants for Secondary Prevention of Recurent Venous Thromboembolism
  • Wisconsin - Update the PHS sponsored clinical practice
  • Women with BRCA-mutated Advanced Stage Ovarian Cancer
  • a retrospective re-review of all negatively adjudicated events (NAE) across three (3) protocols/studies
  • cVAD and QI Registries Manuscripts
  • eConnectivity COPD Study LOI

Add data to my Website